INTRODUCTION {#SEC1}
============

Eukaryotic RNA polymerase II (RNAPII) contains 12 subunits, Rpb1--Rpb12. Rpb1, the largest subunit, has a unique and highly conserved carboxy-terminal domain (CTD) with an essential role in transcription regulation *in vivo* ([@B1]--[@B4]). The RNAPII CTD is required for efficient capping, splicing and cleavage/polyadenylation of pre-mRNAs ([@B5]--[@B7]). It recruits RNA processing, export and histone modifying factors to the transcription complex, coupling mRNA biogenesis to other nuclear processes ([@B3],[@B8]). Nearby the CTD and the RNA exit channel, two RNAPII subunits, Rpb4 and Rpb7, form a heterodimer that protrudes from the enzyme core like a stalk. From this location, the Rpb4/7 heterodimer regulates the interaction with factors important for RNA biogenesis, such as several components of the PIC and the Mediator ([@B9]--[@B11]), and for CTD modification. Indeed, we have shown that the Rpb4/7 heterodimer plays a key role in controlling phosphorylation of the CTD ([@B12]).

The CTD is composed of a repeated heptapeptide motif (26-52 depending upon the organism) with a consensus sequence of Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 ([@B13],[@B14]). Five of the seven residues can be phosphorylated, though Ser2 and Ser5 phosphorylation seem to be the predominant modifications ([@B5],[@B7],[@B15]). In mammals, the CTD can be also acetylated ([@B16]), glycosylated ([@B17],[@B18]) and methylated ([@B19]). The multitude of possible CTD modifications, especially Ser phosphorylations, in combination with the numerous repetitions, generates a wide range of phosphorylation patterns that have been proposed to comprise a "CTD code" ([@B20]). The CTD modifications are dynamic and differentially orchestrate the recruitment of a number of factors required for transcriptional efficiency and RNA processing ([@B21],[@B22]).

Several kinases and phosphatases regulate the levels of CTD phosphorylation ([@B23]). In *Saccharomyces cerevisiae*, four cyclin-dependent kinases (CDKs), Srb10, Kin28, Ctk1 and Bur1 ([@B3],[@B7]) as well as four phosphatases, Rtr1, Ssu72, Glc7 and Fcp1 ([@B23],[@B24]) determine CTD phosphorylation along the transcription cycle. Three additional yeast factors have been involved in the modulation of CTD phosphorylation: Ess1, Sub1 and Rpb4/7 ([@B12],[@B25],[@B26]). The peptidyl prolyl *cis--trans* isomerase Ess1 promotes the function of Ssu72 by isomerising CTD prolines in yeast, while human Pin1 isomerase assists Fcp1 activity ([@B26]--[@B28]). More recently, we have shown that Rpb4/7 heterodimer is important for recruiting Ssu72 and Fcp1 phosphatases ([@B12]). Sub1 globally modulates CTD phosphorylation all along the transcription cycle ([@B25]) although its mechanism remains essentially unknown. Sub1 was originally identified as a transcriptional stimulatory protein, homologous to the human positive coactivator PC4 ([@B29]--[@B33]) that physically interacts with TFIIB, arguing for a role as a coactivator in transcription initiation ([@B34],[@B35]). Indeed, Sub1 has been identified as a component of the pre-initiation (PIC) complex ([@B36]), and having a role in the selection of transcription start site (TSS) ([@B37]). Additionally, Sub1 has also been implicated in other aspects of mRNA biogenesis, such as elongation ([@B38]), transcription termination, and 3΄end formation ([@B39]--[@B41]). Here, we present novel data demonstrating that Sub1 directly interacts with the Rpb4/7 heterodimer via Rpb7 and, in association with Fcp1, modulates the CTD phosphorylation levels. Moreover, our data suggest a role for Sub1 related to the Rpb1 clamp domain, in agreement with the role of Sub1 in the transcription start site (TSS) selection and in the regulation of the RNAPII transcription rate and its interaction with the elongation factor Spt5 ([@B38]).

MATERIALS AND METHODS {#SEC2}
=====================

Yeast strains and media {#SEC2-1}
-----------------------

The strains used are listed in [Table 1 (Supplementary data)](#sup1){ref-type="supplementary-material"}. Strain construction and other genetic manipulations were performed following standard procedures ([@B42]). Oligonucleotide sequences are available upon request.

TAP purification and mass spectrometric analysis {#SEC2-2}
------------------------------------------------

Purification of Sub1--TAP was performed as described in ([@B43]). Sub1--TAP and associated proteins were recovered from cell extracts by affinity selection on an IgG matrix. After washing, TEV protease was added to release the bound material. The eluate was incubated with calmodulin-coated beads in the presence of calcium. After washing, the bound material was released by incubation with EGTA. The eluate was analyzed by Nano-ESI ion-trap mass spectrometry, or by trichloroacetic acid precipitation and analyzed by Western blotting.

Co-immunoprecipitation and western blot analysis {#SEC2-3}
------------------------------------------------

Cells containing TAP-tagged Sub1, and HA-tagged Rpb4/Rpb7 were grown in 200 ml of rich medium to an OD~600~ of 1.0, harvested, washed with water, followed by suspension in 2.5 ml of lysis buffer (20 mM HEPES pH 7.6, 200 mM potassium acetate, 1 mM EDTA pH 8.0, glycerol 10 %) containing protease and phosphatase inhibitors. The cell suspension was flash frozen in liquid nitrogen, and then ground in a chilled mortar to a fine powder. Afterwards, the cell lysate was thawed slowly on ice and transferred to pre-chilled tubes and centrifuged at 13 200 rpm for 20 min. The supernatant was collected and total protein concentration was estimated measuring absorbance at 280 nm in a nanodrop. In experiments where Sub1--TAP was precipitated, the volume of each cell extract containing 25 mg of protein was incubated with 50 μl of IgG Sepharose 6FF (GE Healthcare) slurry for 2 h at 4°C. In experiments where Rpb3 was immunoprecipitated, cell extracts were incubated with 5 μl of anti-Rpb3 antibody for 2 h at 4°C, followed by binding to 30 μl of Protein A Sepharose CL-4B (GE Healthcare) for another 2 h at 4°C. The IPs were extensively washed with lysis buffer and beads were suspended in SDS-PAGE sample buffer. Thereafter they were incubated at 65°C for 20 min and supernatants were loaded onto a SDS-PAGE gel. In the case of Rpb3 IP in whole cell extracts from *wt* and *rpb4*Δ, and *wt* and *rpb1-CTD11* cells containing Sub1--TAP, we proceeded similarly, except that cell lysis was achieved at 4°C using a FastPrep System and 5 mg of total protein was immunoprecipitated. This was also the procedure used to IP Sub1--HA to study Fcp1-MYC/Sub1--HA association. In addition, RNase A and DNAse I treatments were done by incubating washed beads in lysis buffer with 10 mg/ml RNase A at room temperature for 15 minutes or with 10 units/μl DNAse I for 20 min at 37°C in its own buffer.

Western blot analysis was performed using the appropriate antibodies in each case. Anti-phosphoglycerate kinase (Pgk1, 459250; Invitrogen), anti-HA (12CA5, Roche); anti-TAP (CAB1001, Open Biosystems); anti-Rpb1: Y-80 (sc-25758, Santacruz) and 8WG16 (8WG16 (nonP-CTD, Covance); anti-Rpb4 (2Y14; Santa Cruz); anti-Rpb3 (1Y26; Santa Cruz); anti-MYC (9E10, Santa Cruz) were acquired from the indicated vendors. The ECL reagents were used for detection. The signal was acquired on film and/or with a ChemiDoc XRS (Bio-Rad) system and when necessary quantified with the Quantity One software (Bio-Rad).

Expression and purification of recombinant proteins {#SEC2-4}
---------------------------------------------------

### Recombinant Sub1 {#SEC2-4-1}

#### Transfection, virus amplification and protein expression {#SEC2-4-1-1}

Sub1 recombinant bacmid was transfected into adherent High Five™ insect cells (Invitrogen). For virus amplification, recombinant baculovirus stocks were used to infect insect cells for four days. The amplified virus stock (25 ml) was obtained by cell pipetting and centrifugation at 2000 rpm for 5 min and then stored at 4°C. For protein expression, the virus amplification procedure was followed except that the flasks containing adherent insect cells were infected each with 70 μl of the amplified virus stock. Finally, the cells were harvested and frozen.

#### Purification {#SEC2-4-1-2}

Frozen cell pellets were thawed and resuspended in lysis buffer (100 mM Tris pH 7.4, 300 mM NaCl, 6 mM MgCl~2~, 10% (v/v) glycerol, half tablet of EDTA-free Protease Inhibitor Cocktail (Complete™, Roche) and DNase I (Roche)). Cells were sonicated, centrifuged and the supernatant loaded into a HisTrap HP (GE Healthcare) affinity chromatography column equilibrated in binding buffer (100 mM Tris pH 7.4, 300 mM NaCl, 10% (v/v) glycerol). The column was extensively washed with HTA buffer (100 mM Tris pH 7.4, 300 mM NaCl, 10% (v/v) glycerol, 20 mM Imidazole) and washing buffer (100 mM Tris pH 7.4, 1.5 M NaCl, 10% (v/v) glycerol, 20 mM Imidazole), and then re-equilibrated in HTA buffer. Protein was eluted by running a gradient from 0% to 100% HTB buffer (100 mM Tris pH 7.4, 300 mM NaCl, 10% (v/v) glycerol, 250 mM imidazole) in 20 column volumes and collected fractions were analyzed by SDS-PAGE. Selected fractions were pooled, concentrated in a 10 kDa cut-off centrifugal filter (Millipore) and loaded onto a Superdex 200 10/300 GL (GE Healthcare) column equilibrated in GF buffer (20 mM Tris pH 7.4, 100 mM NaCl). The fractions containing the eluted protein were collected and analyzed by SDS-PAGE. The concentrated pool of the fractions containing the protein was frozen in liquid nitrogen and stored at −80°C.

To eliminate the His6-tag at the C-terminus, the protein was incubated with TEV protease (ratio Sub1:TEV 1:50) overnight at 4°C in a mixture containing 1 mM DTT. Digestion was confirmed by SDS-PAGE given the different electrophoretic mobilities of the His-tagged and untagged proteins. The digested protein was purified by recovering it from the supernatant after incubation of the reaction mix with a Ni resin (Ni Sepharose High Performance, Amersham Biosciences), where both undigested protein and TEV protease were captured through their polyhistidine tails. Fractions containing the digested protein were pooled and concentrated using Millipore centrifugal devices.

rRpb4/Rpb7-6His {#SEC2-5}
---------------

We co-expressed and purified Rpb4/7 complex as described ([@B44]) from a plasmid containing Rpb4 and Rpb7, where a six-histidine tail was fused to the C-terminus of Rpb7.

Pull down-assays {#SEC2-6}
----------------

Recombinant Rpb4/Rpb7-6His proteins (3 μg) were incubated in a 20 μl slurry of HisPur Cobalt Resine (Thermo Scientific) in binding buffer (20 mM Tris pH 7.5, 50 mM NaCl) for 2 h at 4°C. Thereafter, the resin with attached Rpb4/Rpb7-6His was washed three times with binding buffer and then Sub1 (3 μg) was added and incubated with the resin for 3 more hours at 4°C in binding buffer. As a negative control, the same amount of Sub1 was incubated in parallel under the same conditions with 20 μl slurry of Cobalt resin without Rpb4/7 proteins. After incubation, the resin was washed four times with washing buffer (20 mM Tris pH 7.5, 100 mM NaCl) and then treated with 15 μl of elution buffer (20 mM Tris pH 7.5, 100 mM NaCl, 150 mM imidazole) for 5 minutes at room temperature. The eluate was collected and analysed by SDS-PAGE. The gel was stained by immersion into Blue Safe staining solution (NZY tech) for several hours.

Chromatin immunoprecipitation (ChIP) {#SEC2-7}
------------------------------------

Chromatin purification, immunoprecipitation, quantitative real-time PCR (qPCR) amplification and data analysis were performed as described ([@B12],[@B25],[@B45]). Briefly, PCR of purified chromatin, following immunoprecipitation, was performed by quantitative real-time PCR with the CFX96 Detection System (Bio-Rad Laboratories, Inc.), using SsoAdvanced™ Universal SYBR^®^ Green Supermix (Bio-Rad) following the manufacturer\'s instructions. Four serial 10-fold dilutions of genomic DNA were amplified using the same reaction mixture as the samples to construct the standard curves. Real-time PCR reactions were performed in triplicate using at least three independent ChIPs. Quantitative analysis was carried out using the CFX96 Manager Software (version 3.1, Bio-Rad). The values obtained for the IP\'d PCR products were compared to those of the total input, and the ratio of the values from each PCR product from transcribed genes to a non-transcribed region of chromosome VII was calculated. Numbers on the y-axis of graphs are detailed in the corresponding figure legend.

RNA isolation and RT-PCR {#SEC2-8}
------------------------

Total RNA was extracted as described ([@B46]) and RT-PCR was performed using the iScript RT reagent Kit (Bio-Rad), following the manufacturer\'s instructions. PCR reactions were performed in triplicate with at least three independent cDNA samples.

Sub1 mutagenesis {#SEC2-9}
----------------

The *sub1-FRN54-56AGG* triple mutation was generated by site-directed mutagenesis of a wild-type copy of *SUB1* cloned into a centromeric plasmid under the control of its own promoter and with a 6x-HA epitope at the C-terminus of the protein. Plasmid expressing the ssDNA binding domain mutation or a *wt* copy of *SUB1* was used to transform the *sub1Δ* mutant and to generate the *sub1-FRN54-56AGG* strain. As a control, the *sub1Δ* strain was transformed with an empty plasmid.

RESULTS {#SEC3}
=======

Sub1 interacts with RNAPII through the Rpb4/7 heterodimer {#SEC3-1}
---------------------------------------------------------

Sub1 influences RNAPII CTD phosphorylation via all four CTD kinases: Kin28, Srb10, Bur1 and Ctk1 ([@B25]). This was observed both genetically and biochemically, including Sub1 effects on kinase activity and/or recruitment to chromatin. Thus, Sub1 can act throughout the transcription cycle as a general regulator of CTD phosphorylation, though we do not understand the biochemical basis of the influence of Sub1 on the activity of all four CTD kinases. We considered two possible explanations: (i) Sub1 enhances the association (or dissociation) of an unidentified, common regulator with the kinases; or (ii) Sub1 influences kinase accessibility to the CTD.

To further explore the first possibility, we decided to analyse the repertoire of Sub1 physical interactions using the TAP strategy ([@B43]). Accordingly, Sub1 was TAP-tagged and associated proteins were MS-analysed. We found among other proteins Spt5, consistent with previous work ([@B38],[@B47]). More interestingly, we identified the Rpb7 subunit of RNAPII as a co-purifying protein. This discovery is extremely interesting since Rpb7, together with Rpb4, is near the CTD, and the heterodimer Rpb4/7 has been functionally related with CTD phosphorylation ([@B12]). To corroborate the specificity of Sub1-Rpb7 association, we purified Sub1--TAP complexes in a double tagged strain, Sub1--TAP Rpb7--HA, and analyzed the TAP purified complex by western blot using the corresponding antibodies to visualize Sub1 and Rpb7 (Figure [1A](#F1){ref-type="fig"}). We confirmed Sub1--TAP/Rpb7--HA association by co-immunoprecipitation (Co-IP), and demonstrated that Sub1 also associates with Rpb4, using a tripled tagged strain Sub1--TAP Rpb7--HA Rpb4--HA (Figure [1B](#F1){ref-type="fig"}). These data indicate that Sub1 associates with the Rpb4/7 heterodimer.

![Sub1 interacts with the RNAPII through the Rpb4/7 heterodimer. (**A**) Sub1 tandem affinity purification from Sub1--TAP and Sub1--TAP Rpb7--HA whole cell extracts (WCE). Input and the purified proteins were precipitated with trichloroacetic acid and analyzed by western blotting using anti-TAP and anti-HA. Anti-Pgk1 was used as a loading control. (**B**) Co-IP performed using WCEs from Sub1--TAP (Rpb7--HA and Rpb7--HA/Rpb4--HA) with IgG Sepharose. Input and IPs were analyzed by western blotting with antibodies to the indicated proteins.](gkw1206fig1){#F1}

Allelic specific interaction between *SUB1* and *RPB4/7* {#SEC3-2}
--------------------------------------------------------

To gain more insight into the functional connection between Sub1 and the RNAPII stalk heterodimer, we analyzed genetic interaction between *SUB1* and *RPB4/7*. As Rpb7, but not Rpb4, is essential for cell viability we worked with the *rpb4Δ* mutant that displays slow growth at 28°C and thermosensitivity at 37°C ([@B48],[@B49]). Deletion of *SUB1* partially suppresses the *rpb4Δ* growth defects at 28 and 34°C, but does not suppress *rpb4Δ* thermosensitivity at 37°C (Figure [2A](#F2){ref-type="fig"}). On the other hand, overexpression of *SUB1* using a strong constitutive or inducible promoter (*ADH1* and *GAL1*, respectively; Figure [2A](#F2){ref-type="fig"} and [Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}), dramatically reduces *rpb4Δ* cell growth. In addition, we used an Rpb7-TAP strain where the C-terminal Rpb7-TAP tag causes growth defects ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}). In this case, the growth defects at 28 and 34°C are also partially rescued by *SUB1* deletion ([Supplementary Figure 1B](#sup1){ref-type="supplementary-material"}). Therefore, *SUB1* genetically interacts with *RPB4* and *RPB7*, in agreement with the association of Sub1 with the Rpb4/7 heterodimer (Figure [1](#F1){ref-type="fig"}). However, this genetic result was unexpected, because deletion of *SUB1* mostly displays negative genetic interactions with mutations compromising transcription initiation and elongation, for instance mutations in TFIIB, TFIIE, TFIIH, Kin28, Ctk1, Bur1, Fcp1, Spt5/Spt4 ([@B25],[@B36],[@B38],[@B41],[@B50]). The positive genetic interaction between *SUB1* and *RPB4* and *RPB7* suggests that Sub1 may be gaining a function when the heterodimer function is altered.

![Allelic specific interaction between *SUB1* and *RPB4/7*. (**A**) Genetic interaction between *SUB1* and *RPB4. SUB1* deletion partially suppresses the slow growth phenotype of the *rpb4*Δ strain at 28 and 34°C, while overexpression of *SUB1* exacerbates it. *SUB1* was overexpressed from a strong constitutive *ADH1* promoter. Serial dilutions (1:10) of *wt* and mutant strains were spotted on selective SC media and grown for 2--3 days at the indicated temperatures. (**B**) Genetic interaction between *SUB1* and the *rpo21-4* mutation localized in the Rpb1 foot domain. Deletion of *SUB1* partially suppresses the slow growth phenotype of *rpo21-4* strain at 28, 34 and 37°C. Cells were assayed as in (A) in rich media. (**C**) *sub1Δ* and *rpb1-L1397S* are synthetically lethal. A diploid yeast strain heterozygous for both *SUB1* and *rpb1-L1397S* was sporulated and the meiotic progeny were separated by tetrad dissection, and allowed to grow for 3 days. Forty-six tetrads were dissected, with thirty showing tetratype segregation pattern (TT, five of which are shown), nine showing paternal ditype (PD) and 7 a nonpaternal ditype (NPD). The genotype of the resulting colonies was inferred by growth or no growth on selective medium and 37°C. The *sub1Δ* deletion is indicated as (−), and *wt* (+); and in the case of *RPB1*, (+) means *rpb1-L1397S* and (−) *wt*. Cells deleted for *rpb1-L1397S* alone (− −) show a slow growth phenotype, as reported previously. Double mutants cells (− +) were unviable. (**D**) There is not genetic interaction between *sub1Δ* and the *rpb1--19* mutation on the jaw domain of Rpb1. Serial dilution assay as in (B) showing that single and double mutants, *rpb1--19* and *rpb1-19sub1Δ* respectively, display similar growth.](gkw1206fig2){#F2}

To investigate the specificity of this interaction, we analyzed the genetic interaction between *SUB1* and *RPB1*. For that purpose we choose three *rpb1* alleles. Two of them are functionally and structurally related to Rpb4/7, *rpo21-4* and *rpb1-L1397S*, which are localized in the foot and clamp domains, respectively ([@B51],[@B52]); and a third one, *rpb1-19*, is localized in the *jaw* domain ([@B53]), far from Rpb4/7 within the context of RNAPII complex ([@B54]).

The foot domain is a conserved region of RNAPII located at the surface of the complex, with poor or no conservation in their paralogs, Rpa190 (RNAPI) and Rpc160 (RNAPIII), or in their homologs in archaea and bacteria ([@B55],[@B56]). The foot domain is crucial for the assembly and stability of RNAPII, by ensuring the correct association of Rpb1 with Rpb6 and Rpb4/Rpb7. In fact, assembly defects alter not only transcriptional activity but also RNAPII-DNA association and CTD phosphorylation ([@B51]). Thus, we used the *rpo21-4* (*rpb1-W954-LELE-955*) foot mutant ([@B57],[@B58]) where the association of the Rpb4/7 heterodimer with RNAPII is reduced ([@B51]). This mutant displays reduced growth at 28°C and exhibits slow growth at 34°C and 37°C (Figure [2B](#F2){ref-type="fig"}). Interestingly, we observed that deletion of *SUB1* suppressed *rpo21-4* growth defects at 34 and 37°C, whereas *sub1Δ* does not affect growth at these temperatures in a *wt RPB1* background. Hence, *rpo21-4* suppression recapitulates the growth defects observed in the double mutant *rpb4Δsub1Δ*. These data indicate that *sub1Δ* suppresses mutations compromising the function of the Rpb4/7 heterodimer, either by deletion of *RPB4* or by a mutation on the Rpb1 foot domain.

The RNAPII clamp is a flexible structural element postulated to intervene in the regulation of DNA access to the cleft ([@B59]). An open clamp is observed in the absence of the Rpb4/7 heterodimer ([@B56]), while the complete enzyme presents a closed clamp conformation ([@B54]). Rpb4/7 plays a role in the mobility of this domain during transcription initiation ([@B60],[@B61]). Therefore, we studied whether a *sub1Δ* deletion might genetically interact with the *rpb1-L1397S* clamp mutation. Specifically, this amino acid substitution occurs in the Rpb1 α-47b helix of the Switch 1 loop of the catalytic site within the structure of the RNAPII. In fact, the Switch 1 loop holds the DNA template strand at position +2/+3 downstream of the catalytic Mg^2+^ ([@B62]). The *rpb1-L1397S* mutant displays slow growth at 28°C, cold and thermosensitivity and reduced RNAPII association with genes ([@B52]). Both, *rpb1-L1397S* and *sub1Δ* show upregulation of *IMD2* transcription ([@B38],[@B52]), which is a hallmark of defects on TSS selection ([@B63]). Indeed, it has been shown that Sub1 participates in TSS selection ([@B37]). We then crossed the *rpb1-L1397S* mutant with the *sub1Δ* deletion mutant. The diploid cells were sporulated and the tetrads dissected. Interestingly, *sub1Δ* conferred synthetic lethality in combination with *rpb1-L1397S* (Figure [2C](#F2){ref-type="fig"}). This could be explained as a result of the additive effect of both mutations, *sub1Δ* and *rpb1-L1397S*, reducing RNAPII gene occupancy during transcription to levels that may be incompatible with cell viability ([@B41],[@B45],[@B52]). Also, synthetic lethality may be the result of the combined defect on elongation ([@B38],[@B64],[@B65]), and/or on the TSS selection ([@B37],[@B52]). In any case and importantly, this result shows the essentiality of Sub1 in a context where the clamp function is impaired.

We also tested the effect of *SUB1* deletion on the *rpb1-19* jaw mutant. In this case no genetic interaction was observed (Figure [2D](#F2){ref-type="fig"}). As noted above, this domain is situated far from Rpb4/7 within the RNAPII structure ([@B54]). All of these data indicate an allele-specific interaction between *sub1Δ* and mutations localized within or proximal to the Rpb4/7 heterodimer in the context of the RNAPII 10 subunit complex. In addition, they corroborate the specificity of a functional relationship between Sub1 and the Rpb4/7 heterodimer consistent with their physical association (Figure [1](#F1){ref-type="fig"}).

A functional Rpb4/7 heterodimer is a requisite for Sub1 recruitment to gene promoters {#SEC3-3}
-------------------------------------------------------------------------------------

We next asked if Sub1 association with promoter DNA was affected in *rpb4Δ* cells, because in these cells Rpb7 levels are significantly reduced, along with diminished association of RNAPII with DNA ([@B66]--[@B68]). Thus, we performed chromatin immunoprecipitation (ChIP) using the *wt* and *rpb4Δ* Sub1--HA tagged strains, where in addition to Sub1, we also analyzed Rpb1 and Rpb3 occupancy at the promoters of several constitutively transcribed genes. In agreement with published data ([@B12]), Rpb4 is required for proper RNAPII occupancy to gene promoters as inferred from reduced Rpb1 and Rpb3 association levels (Figure [3A](#F3){ref-type="fig"}, left and middle panel, respectively). Interestingly, Sub1 occupancy was also dramatically decreased in *rpb4Δ* cells. Thus, \<20% of Sub1 was associated with chromatin in cells lacking Rpb4 (Figure [3A](#F3){ref-type="fig"}, right panel). To determine if this was simply a consequence of reduced RNAPII occupancy, we calculated Sub1/Rpb1 and Sub1/Rpb3 ratios, and observed that this was not the case, because the levels of Sub1 association with chromatin were even lower than those of Rpb1 and Rpb3 (Figure [3B](#F3){ref-type="fig"}). We observed that these effects on chromatin association are not due to diminished Sub1--HA protein levels, as they are unaltered in *rpb4Δ* cells (Figure [3C](#F3){ref-type="fig"}). Although we did not know whether Sub1 directly interacts with Rpb7 and/or Rpb4, it is possible that reduced Rpb7 levels in *rpb4Δ* cells (Figure [3D](#F3){ref-type="fig"}, and ([@B66]--[@B68])) could account for the Sub1 defect on promoter association. We also tested Sub1--TAP association with chromatin in the clamp mutant, *rpb1-L1397S*. No effect was observed: Sub1 was properly detected at gene promoters in the mutant cells (Figure [3E](#F3){ref-type="fig"}, left panel) with no change in Sub1--TAP levels (Figure [3E](#F3){ref-type="fig"}, right panel).

![A functional Rpb4/7 heterodimer is a requisite for Sub1 recruitment to gene promoters. (**A**) Chromatin immunoprecipitation (ChIP) analyses were performed using *wt* and *rpb4*Δ strains. Left panel: Rpb1 binding to the promoter (P) of four constitutively expressed genes, *ADH1, PGK1, PMA1* and *YEF3* was examined by qPCR. Results were quantified (see Materials and Methods), and relative Rpb1 binding in *rpb4*Δ cells is plotted relative to that in *wt* cells (set equal to 100). The data plotted correspond to mean values from at least three independent experiments, and the error bars represent standard deviations. Middle and Right panels show relative Rpb3 and Sub1--HA binding, respectively, plotted as for Rpb1. (**B**) Plots of Sub1--HA/Rpb1, Sub1--HA /Rpb3 ratios in wild-type (*wt*) and *rpb4*Δ using data from Figure [1A](#F1){ref-type="fig"}. (**C**) Whole cell extracts (WCE) were prepared from wild-type (*wt*) and *rpb4*Δ strains expressing Sub1--HA and analyzed by western blotting using the following antibodies: anti-HA, anti-Rpb1 (8W16G), anti-Rpb3, anti-Rpb4 (2Y14) and anti-Pgk1 as a control for total protein. (**D**) Whole cell extracts (WCE) were prepared from wild-type (*wt*) and *rpb4*Δ strains expressing Rpb7--HA and analyzed by Western blotting using anti-HA, anti-Rpb4 and anti-Pgk1. (**E**) Left panel: ChIP analysis in *wt* and *rpb1-L1397S* cells as in (A) to analyze Sub1--TAP occupancy at the promoter (P) of three constitutively expressed genes (*PMA1, ADH1* and *PGK1*) and to the promoter of the *IMD2* inducible gene, whose expression is regulated by Sub1 ([@B38],[@B82]), and is upregulated in the *rpb1-L1397S mutant* ([@B52]). Right panel: WCE were prepared from wild-type (*wt*) and *rpb1-L1397S* strains expressing Sub1--TAP and analyzed by Western blotting using anti-TAP and anti-Pgk1 as loading control.](gkw1206fig3){#F3}

In conclusion, our data indicate that a functional Rpb4/7 heterodimer is required for Sub1 association with gene promoters. It has been suggested that Sub1, together with TFIIB, functions in the recruitment of RNAPII to constitutively transcribed genes. Hence, the reduced level of Sub1 bound to promoters in *rpb4Δ* cells is likely not due to reduced RNAPII recruitment. Rather, it is more likely that Sub1 cannot be maintained stably associated to the DNA, and/or disassociates faster from the promoter, in the absence of the Rpb4/7 heterodimer.

Sub1 associates with the Rpb4/7 heterodimer via direct interaction with Rpb7 {#SEC3-4}
----------------------------------------------------------------------------

We next proceeded with *in vitro* assays to investigate whether the Rpb4/7-Sub1 interaction may be direct. For that purpose we carried out pull down assays using recombinant Sub1 and Rpb4/7 proteins. As shown in Figure [4A](#F4){ref-type="fig"}, Sub1 remains associated with Rpb4/7 after extensive washing, indicating that it directly interacts with the heterodimer. This result demonstrates for the first time that Sub1 interacts directly with the RNAPII complex. However, we did not know the direct target of Sub1: Rpb7, Rpb4 or both.

![Sub1 associates with the Rpb4/7 heterodimer via direct interaction with Rpb7. (**A**) Pull down assay. 15% SDS-PAGE gel showing bands corresponding to recombinant proteins rSub1 and rRpb4/Rpb7-6His. (lanes 2 and 3, respectively) and pull down assays where rSub1 and a Co^2+^ resin have been incubated in the absence (lane 4) and in the presence of rRpb4/Rpb7-6His (lane 5). **(B)** Co-IP performed with IgG Sepharose using WCEs from *wt* strains expressing Sub1--TAP and Rpb7--HA/Rpb4--HA and from *rpb4Δ* cells expressing Sub1--TAP and Rpb7--HA. Input and IPs were analyzed by Western blotting with antibodies to the indicated proteins. (**C**) Co-IP performed on WCEs from Sub1--TAP cells (*wt* and *rpb4*Δ) using anti-Rpb3 antibody. As a control, the same amount of cell extracts was incubated only with Protein A sepharose. Inputs and IPs were analyzed by Western blotting with antibodies to the indicated proteins.](gkw1206fig4){#F4}

To identify the direct target of Sub1, we co-immunoprecipitated Sub1--TAP and Rpb7--HA using whole cell extracts from a *wt* strain expressing Rpb4--HA or from the *rpb4Δ* strain, and analyzed its association by western blot to determine the contribution of Rpb4 to Sub1 interaction with the heterodimer. Surprisingly, we observed that Sub1 still interacts with Rpb7 when lacking Rpb4 (Figure [4B](#F4){ref-type="fig"}). In fact, the interaction between Sub1 and Rpb7 is similar in isogenic *RPB4 wt* and *rpb4Δ* cells, though Rpb7--HA levels are reduced in the absence of Rpb4 as previously described ([@B66]--[@B68]). Therefore, from all these data we conclude that the target of Sub1 is Rpb7, in agreement with identifying only Rpb7 in the Sub1--TAP purifications (Figure [1A](#F1){ref-type="fig"}). This result also supports our conclusion that reduced association of Sub1 to chromatin in *rpb4Δ* cells is due to decreased Rpb7 levels (Figure [3A](#F3){ref-type="fig"}, [D](#F3){ref-type="fig"}). In summary, our data clearly demonstrate that Sub1 interacts with Rpb4/7 and indicate that this interaction could explain how Sub1 is able to modulate CTD phosphorylation.

Additionally, we tested if Sub1 association with the core polymerase is influenced by Rpb4. For that purpose we immunoprecipitated Rpb3 from *wt* and *rpb4Δ* whole cell extracts expressing Sub1--TAP, and analyzed Sub1 association by western blot. As shown in Figure [4C](#F4){ref-type="fig"}, Sub1--TAP associates with RNAPII in the absence of Rpb4. Therefore, our results indicate that Sub1 targets Rpb7 to be associated with the RNAPII, though we cannot exclude that it can also interact with other RNAPII subunits. On the other hand, and consistent with *sub1Δ* suppression of *rpb4Δ* (Figure [2A](#F2){ref-type="fig"} and [Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}), Sub1 may have a negative effect during transcription when interacting with Rpb7 in the absence of Rpb4.

Sub1 carboxy-terminal region is important for the functional interaction with Rpb4/7 {#SEC3-5}
------------------------------------------------------------------------------------

Sub1 is a 292-residue polypeptide showing strong similarity to its human homolog PC4 (127 amino acids) over a 65-residue region (amino acids 41--105) that includes a single-stranded DNA binding domain (DBD) and sequences essential for co-activator function ([@B33],[@B34],[@B69]). Although Sub1 is highly related to PC4, yeast Sub1 is much larger than human PC4 (33 KDa versus 15 KDa ([@B34],[@B35],[@B39]). Specifically, Sub1 has an extra carboxy-terminal (CT) region of ∼190 amino acids with unknown function(s), suggesting that Sub1 might have functional differences from PC4 due to this additional domain. Like PC4, Sub1 has the capacity to tightly bind melted DNA and single-stranded DNA *in vitro* ([@B34]) and both have been implicated in DNA-dependent processes other than transcription, such as DNA repair and replication ([@B69]--[@B72]).

To explore which Sub1 region is involved in Rpb4/7 interaction, we investigated the importance of the Sub1 CT region and DNA-binding domain (DBD) relative to its interaction with Rpb4/7. For that purpose, two mutants were generated: (i) a strain where the chromosomal CT region of Sub1 (from amino acid 105 to stop) was substituted by a 6xHA epitope; and (ii) a triple-mutant, *sub1-FRN54-56AGG*, which encodes Phe54 → Ala, Arg55 → Gly and Asn56 → Gly replacements. Mutations in the corresponding residues in PC4 (Phe77, Lys78 and Lys79) severely affected the binding of PC4 to ssDNA *in vitro* ([@B33]). Protein expression of all the mutants was confirmed by western blot ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}, upper panel). As shown, the levels of the Sub1ΔCT-HA protein are very low compared to that of Sub1 levels in the isogenic *wt* and *sub1-FRN54-56AGG* cells, and this effect is not due to defective transcription ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}, lower panel). In *sub1ΔCT* cells, where Sub1 contains only the DNA binding domain, the protein becomes very unstable.

We next analyzed the association of Sub1--HA with the promoters of several constitutively transcribed genes (*PMA1, PGK1, PYK1*), and with the promoter of the Sub1 target gene *IMD2*, in normal growth conditions (Figure [5A](#F5){ref-type="fig"}). For that purpose, we performed ChIP assays first in *wt*, and *sub1ΔCT* expressing Sub1--HA and Sub1ΔCT-HA, respectively (Figure [5A](#F5){ref-type="fig"}, left panel). As expected, Sub1--HA was efficiently recruited to the promoter of all of genes tested in *wt* cells. However, unexpectedly and very interestingly, Sub1 association was either unaffected or only slightly affected in *sub1ΔCT* cells (Figure [5A](#F5){ref-type="fig"}, left panel), although Sub1ΔCT-HA protein levels were extremely low ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}). This result indicates that the C-terminal domain of Sub1 is not required for Sub1 occupancy of gene promoters, but can contribute to it. Thus, the CT domain, which is not present in PC4, might be involved in other functions, such as the regulation of Sub1 binding to the DNA and/or in the interaction with other factors. In contrast, and as expected, Sub1 association was almost abolished in *sub1-FRN54-56AGG* cells (Figure [5A](#F5){ref-type="fig"}, right panel), which is consistent with the importance of these residues for PC4 DNA binding capacity and with the clear homology between Sub1 and PC4 in the DBD ([@B33],[@B69],[@B73]).

![Sub1 carboxy-terminal region is important for the functional interaction with Rpb4/7. (**A**) Left panel: Chromatin immunoprecipitation (ChIP) analyses were performed using *wt* and *sub1ΔCT-HA* strains expressing Sub1--HA. Sub1 binding to the promoter (P) of three constitutively expressed genes, *PMA1, PGK1, PYK1* and the inducible gene *IMD2* was examined by qPCR. Results were quantitated (as in figure [3](#F3){ref-type="fig"}), and relative Sub1--HA binding in *sub1ΔCT-HA* cells is plotted relative to that in *wt* cells (set equal to 100). Right panel, Chromatin immunoprecipitation (ChIP) analyses were performed using *wt, SUB1* deletion mutant (*sub1*Δ), and the DNA binding mutant *sub1-FRN54-56AGG*. (**B**) Genetic interaction between *sub1ΔCT* and *rpb4Δ. SUB1* deletion partially suppresses the slow growth phenotype of *rpb4*Δ strain at 28 and 34°C in rich medium. Serial dilutions (1:10) of *wt* and mutant strains were spotted on rich medium and grown for 2--3 days at the indicated temperatures. (**C**) There is no genetic interaction between the ssDNA binding domain of Sub1 and *RPB4*. Serial dilutions (1:10) of the indicated strains were spotted on selective SC medium and grown for 2--3 days at the indicated temperatures. (**D**) ChIP analyses were performed in *wt* and *rpb4Δ* cells expressing Sub1ΔCT-HA protein.](gkw1206fig5){#F5}

We further tested the genetic interaction between *RPB4* and the Sub1 CT region and Sub1 DBD. Interestingly, deletion of the Sub1 CT region in *rpb4Δ* cells rescues their growth defects at 28 and 34°C (Figure [5B](#F5){ref-type="fig"}), recapitulating the effects of the *SUB1* complete deletion (see Figure [2A](#F2){ref-type="fig"}). In contrast, no effect was observed when the *SUB1* DBD mutation was expressed in the *rpb4Δ sub1Δ* cells (Figure [5C](#F5){ref-type="fig"}, [Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}). Thus, it is likely that Sub1 may need the CT region to interact with Rpb4/7 upon its association to promoters through the DBD. This agrees with some decrease of Sub1 crosslinking at the promoters in the absence of the CT region (Figure [5A](#F5){ref-type="fig"}, left panel). If our hypothesis is correct, we should observe that association of Sub1ΔCT-HA with gene promoters decreases when lacking *RPB4*. Indeed, this is what we observed when we performed ChIP assays in *sub1ΔCT-HA* and *sub1ΔCT-HA rpb4Δ* cells (Figure [5D](#F5){ref-type="fig"}). Sub1ΔCT-HA association with the gene promoters is significantly reduced in *rpb4Δ* cells. Though this reduction (∼60--50%) is lower than the one observed for Sub1--HA *wt* in the absence of Rpb4 (∼80%, Figure [3A](#F3){ref-type="fig"}), it supports our idea that Sub1-CT region may interact with Rpb4/7 to be stably associated with the chromatin. Moreover, our data corroborate the genetic interaction between *SUB1* and *RPB4* and offer insight into the function(s) of Sub1 CT region, which has not been identified previously.

Sub1 and Fcp1 are components of the same complex {#SEC3-6}
------------------------------------------------

Several facts suggested that Sub1 and Fcp1 interact, at least as part of the same complex where the heterodimer Rpb4/7 is present. First, we reported that Sub1 is a regulator of Fcp1 and our data indicated that a function of Sub1 is to facilitate accumulation of Fcp1, likely by directly or indirectly increasing its stability. Additionally we showed that Fcp1 crosslinking to DNA was significantly reduced in the *sub1Δ* strain, with comparable reductions at both 5΄ coding and terminator regions ([@B41]). Second, a number of findings suggested that Rpb4/7 might recruit Fcp1 to regulate CTD modifications, among them our more recent work showing that Fcp1 association to chromatin is impaired during the entire transcription cycle in the absence of Rpb4 ([@B12]). Furthermore, *in vitro* binding and yeast two-hybrid assays in *S. pombe* and *D. melanogaster*, respectively, showed that Rpb4 interacts with Fcp1 ([@B74],[@B75]). Structural and biochemical studies also suggest that in *S. cerevisiae* Fcp1 might also interact with RNAPII through Rpb4/7 ([@B76]). Third, here we have clearly shown that Rpb4/7 interact with Sub1.

To investigate if Sub1 and Fcp1 interact, we performed CoIPs assays. We detected Fcp1-MYC by IP of Sub1--HA (Figure [6A](#F6){ref-type="fig"}). Furthermore, CoIPs assays showed that Sub1-Fcp1 interaction is resistant to treatment with either DNAse I or RNAse A, and only strong washing conditions, such as high salt (500 mM NaCl), weakened their association (Figure [6B](#F6){ref-type="fig"}). These data strengthen the conclusion that Sub1 is functionally related to RNAPII CTD phosphorylation and indicates that this function is likely to be executed via its interaction with Rpb4/7 and Fcp1. Moreover, our data uncover the existence of a physical and functional connection between Sub1, Rpb4/7 and Fcp1 which is important to maintain proper RNAPII phosphorylation levels, key in the biogenesis of mRNAs.

![Sub1 and Fcp1 are components of the same complex. (**A**) Co-IP performed on WCEs from Sub1--HA and Sub1--HA Fcp1-MYC cells using an anti-HA antibody. Inputs and IPs were analyzed by Western blotting with antibodies to the indicated proteins (anti-MYC and anti-HA for Fcp1 and Sub1, respectively). (**B**) Same as in (A), except that in the fourth IP the beads were washed with lysis buffer containing 500 mM NaCl, and second and third IPs were treated with DNAse I and RNAse A, respectively.](gkw1206fig6){#F6}

A full length Rpb1-CTD is required for efficient Sub1 association to gene promoters {#SEC3-7}
-----------------------------------------------------------------------------------

Our data suggest that Sub1 may regulate CTD phosphorylation through interaction with Rpb4/7 and Fcp1, based on demonstration that Rpb4/7 is required for CTD dephosphorylation by CTD phosphatases ([@B12]). In addition, in an extensive genetic interaction network, *SUB1* and the CTD interact ([@B77]). This study revealed a number of significant genetic interactions as the CTD was progressively shortened. Indeed a negative genetic interaction between *rpb1-CTD11* (with a CTD containing only eleven heptad repeats) and the *SUB1* deletion was observed. Although we did not find a direct interaction between Sub1 and the CTD, we wondered if the CTD, as well as Rpb4/7, may contribute to Sub1 occupancy at promoters and to its association with RNAPII. To answer the question we took advantage of several CTD truncation mutants containing 11 and 20 repeats (*rpb1-CTD11* and *rpb1-CTD20*), respectively ([@B77]). First, we deleted *SUB1* in the *rpb1-CTD11* mutant to confirm the genetic interaction. As shown in Figure [7A](#F7){ref-type="fig"}, deletion of *SUB1* exacerbates the growth phenotype of the *rpb1-CTD11* cells. We next decided to investigate if Sub1 association to gene promoters was dependent on the length of the CTD. For that purpose, we TAP tagged Sub1 in the *RPB1-CTD wt, rpb1-CTD11* and *rpb1-CTD20* strains and we analyzed Sub1--TAP occupancy by ChIP in several gene promoters (Figure [7B](#F7){ref-type="fig"} and [C](#F7){ref-type="fig"}). Interestingly, the occupancy of Sub1 in these regions gets worse as the number of CTD repeats decreases. Thus, in *rpb1-CTD11* cells, Sub1 occupancy of gene promoters is significantly diminished when compared to *wt* cells (Figure [7B](#F7){ref-type="fig"}, left panel) and this is not due to reduced Sub1 levels (Figure [7B](#F7){ref-type="fig"}, right panel). On the other hand, in *rpb1-CTD20* cells, Sub1 association with chromatin diminishes only slightly (Figure [7C](#F7){ref-type="fig"}) compared to *wt* cells. Moreover, the effect on Sub1 occupancy dependent on CTD length is specific for Sub1, as no effect is observed for Rpb4 and Rpb3 crosslinking in *rpb1-CTD11* cells (Figure [7B](#F7){ref-type="fig"}).

![A full length Rpb1-CTD is required for efficient Sub1 association to gene promoters. (**A**) Genetic interaction between *sub1*Δ *and rpb1-CTD11*. The *sub1Δ* deletion increases the slow growth phenotype of *rpb1-CTD11* strain at 16, 28 and 37°C. Serial dilutions (1:10) of *wt* and mutant strains were spotted on rich medium and grown for 2--3 days at the indicated temperatures. (**B**) Chromatin immunoprecipitation (ChIP) analyses were performed using *wt* and *rpb1-CTD11* strains. Left panel: Rpb3, Rpb4 and Sub1--TAP binding to the promoter (P) of three constitutively expressed genes, *PMA1, ADH1* and *PGK1*, and to the promoter of the *IMD2* inducible gene, was examined by qPCR. Results were quantitated (see Material and Methods), and relative Rpb3, Rpb4 and Sub1--TAP binding in *rpb1-CTD11*cells is plotted relative to that in *wt* cells (set equal to 1). Right panel: WCE were prepared from wild-type (*wt*) and *rpb1-CTD11* strains expressing Sub1--TAP and analyzed by Western blotting using the indicated antibodies. (**C**) Same as in (B) for *wt* and *rpb1-CTD20* strains. (**D**) Left panel: Co-IP performed on WCEs from Sub1--TAP cells (*wt* and *rpb1-CTD11*) using an anti-Rpb3 antibody. As a control, the same amount of cell extract was incubated with Protein A Sepharose alone. Inputs and IPs were analyzed by Western blotting with antibodies to the indicated proteins. Right panel: Values from the quantification of Sub1-TAP and Rpb3 immunoreactive signals from three experiments were calcuated and Sub1-TAP/Rpb3 mean ratios were plotted (arbitrary units), where error bars represent standard deviations.](gkw1206fig7){#F7}

We next asked if Sub1--TAP association to the RNAPII was also affected when the CTD has only eleven repeats. In this case, we performed CoIP assays using *wt* and *rpb1-CTD11* whole cell extracts (Figure [7D](#F7){ref-type="fig"}). First, we analyzed levels of Rpb1 by western blot using whole cell extracts from *wt, rpb1-CTD11* and *rpb1-CTD20* cells. We used two different antibodies: 8WG16 directed against the CTD and Y-80 that recognizes the N-terminus of Rpb1 (Figure [7B](#F7){ref-type="fig"}, right panel and Figure [7C](#F7){ref-type="fig"}, right panel). We observed that levels of Rpb1 were significantly decreased in *rpb1-CTD11* when analyzed with the 8WG16 antibody, as previously shown ([@B77]) and in agreement with the number of CTD repetitions (11 versus 25--26 in an otherwise *wt* cell). However, Y-80 antibody showed increased Rpb1 levels. These effects were not observed in the *rpb1-CTD20* whole cell extracts, where Rpb1 levels are similar to the *wt* cells independently of the Rpb1 antibody used. We then performed Co-IP experiments using the anti-Rpb3 antibody, as no differences in Rpb3 levels were observed in the isogenic *wt* and *rpb1-CTD11* cells. Very interestingly, and in agreement with the ChIP data, there is less Sub1--TAP associated to the RNAPII in the *rpb1-CTD11* mutant than in the *wt* cells (Figure [7D](#F7){ref-type="fig"}). These results underscore the conclusion that Sub1 and the Rpb1-CTD are functionally related, which support the role of Sub1 in CTD phosphorylation ([@B25]). We conclude that Rpb4/7 and the Rpb1-CTD are important for Sub1 association with DNA. Furthermore, at least during transcription initiation, Sub1 appears to be localized to a region near the CTD and Rpb4/7 of RNAPII. These results support the conclusion that Sub1 affects clamp function and modulates CTD phosphorylation throughout the transcription cycle.

DISCUSSION {#SEC4}
==========

The data presented here provide novel insight into how the transcriptional coactivator Sub1 modulates RNAPII transcription through interaction with Rpb4/7. Our findings that Sub1 directly interacts with the Rpb4/7 heterodimer, associates with Fcp1, and is genetically and functionally related to the CTD, explain how Sub1 modulates RNAPII phosphorylation, which crucially regulates the biogenesis of mRNAs. We also provide evidence indicating that Sub1 contributes to RNAPII clamp function elucidating Sub1 role during the transition from the open to the closed complex formation, thus facilitating transcription elongation.

Sub1, as a PIC component, directly interacts with Rpb4/7 {#SEC4-1}
--------------------------------------------------------

We show that Sub1 interacts with Rpb4/7, most likely via Rpb7 because Sub1 binds RNAPII in the absence of Rpb4 (Figure [4](#F4){ref-type="fig"}). However, a fully functional heterodimer seems to be important for Sub1 association with chromatin, as Sub1 crosslinking to gene promoters is significantly reduced in the *rpb4* null mutant (Figure [3](#F3){ref-type="fig"}). It is likely that the reduced levels of Rpb7 in the *rpb4Δ* cells account for Sub1 chromatin association defects. The apparent discrepancy between the CoIP and ChIP experiments suggests that, while Rpb4 is not required for Sub1 interaction with RNAPII, a functional Rpb4/7 is necessary for Sub1 to stably associate with chromatin after RNAPII recruitment to the PIC. We propose a model where Sub1 is recruited to RNAPII through interaction with Rpb4/7, TFIIB ([@B36],[@B50],[@B78]) and DNA. Once at the PIC, Sub1 interacts with Rpb4/7 via its C-terminal region (Figures [5](#F5){ref-type="fig"} and [8](#F8){ref-type="fig"}) to keep associated to RNAPII and chomatin.

![Schematic model showing the hypothetical localization of Sub1 during transcription initiation. Sub1 is bound to the promoter by interacting with upstream DNA at the junction between single- and double-stranded DNA ([@B36]) through its DNA Binding Domain (Sub1 DBD) (Figure [5](#F5){ref-type="fig"}). The proposed localization of Sub1 in this model explains the reported physical (solid arrow) and genetic (dashed arrow) interaction of Sub1 with TFIIB ([@B35],[@B50]). The intrinsically-disordered C-terminal domain of Sub1 (Sub1 CT) may extend to directly interact with the Rpb4/7 heterodimer, as suggested by the specific genetic interaction between this domain and *RPB4* (Figure [5](#F5){ref-type="fig"}), and the physical direct interaction with Rpb7 (Figure [4](#F4){ref-type="fig"}). The genetic interaction between Sub1 and Rpb1 clamp (Figure [2C](#F2){ref-type="fig"}) is also illustrated. In addition, the model shows the connections of Fcp1 phosphatase with Rpb4 and Sub1 revealed by our genetic (Allepuz-Fuster *et al.*, Calvo & Manley, 2005) and CoIP assays (Figure [6](#F6){ref-type="fig"}), and consistent with the structural data ([@B76]). Our proposed model suggests that Sub1 may influence Rpb1-CTD phosphorylation ([@B25]) and Rpb1 clamp functionality through its interaction with Rpb4/7, which could also explain the already suggested role of Sub1 both during transcription initiation ([@B36],[@B37]) and elongation ([@B38]).](gkw1206fig8){#F8}

*SUB1* was originally isolated as an allele-specific suppressor of two TFIIB mutations (E62G and R78H) ([@B35]), located within the B-reader region (helix and loop, respectively) ([@B79]). Deletion of *SUB1* is synthetically lethal when combined with these two mutations and, in agreement, overexpression of *SUB1* is required for suppression of their cold sensitive phenotypes ([@B35]). Moreover, a specific interaction between Sub1 and TFIIB has also been described ([@B35]); and TFIIB is required for Sub1 recruitment to the promoters of constitutively transcribed genes ([@B78]).

Sub1 was subsequently identified as a PIC component ([@B36]). In this elegant study, ChIP data suggest that Sub1 mainly localizes to the promoter region of active genes in a manner dependent upon TBP. Additionally, FeBABE cleavage experiments indicate that Sub1 is located near the leading edge of the *HIS4* transcription bubble, which is also close to the TFIIB-linker helix ([@B79],[@B80]). This is in agreement with a direct interaction between Sub1 and TFIIB ([@B35]). They proposed a model where Sub1 is first recruited to the PIC by protein interactions, likely with TFIIB, and at that point both factors would cooperate in promoter melting. Then, the interaction of Sub1 with DNA would stabilize the open complex, thus promoting transcription initiation and promoter clearance. Hence, in this model, Sub1, upon promoter melting, can interact with the non-template strand or perhaps both strands at the upstream junction between single- and double-stranded DNA. In fact, the residues mutated in TFIIB that specifically interact with *SUB1* are in the B-reader, which has been proposed to act in the capture of the template strand within the RNAPII active site ([@B79]).

Genetic data also suggest that Sub1, once bound to gene promoters, could help TFIIE and TFIIH to maintain the PIC in a stable but inactive conformation in the open complex ([@B36]). At this point, we propose that Sub1 may interact with Rpb4/7. One hypothesis is that the interaction is mediated by the carboxy-terminal region of Sub1. The intrinsically-disordered nature of the Sub1 C-terminal domain could allow the protein to span the distance between the bubble upstream junction and the RNAPII stalk (Figure [8](#F8){ref-type="fig"}). This interaction would help to maintain Sub1 associated to gene promoters until the next step in transcription. Supporting this idea, we identified a specific genetic interaction between *sub1ΔCT* and *rpb4Δ* (Figure [5B](#F5){ref-type="fig"}), and showed that the association of Sub1ΔCT with gene promoters is significantly reduced in the absence of *RPB4* (Figure [5D](#F5){ref-type="fig"}). In contrast, a mutation altering Sub1 DNA binding does not affect growth of *rpb4Δ* mutants (Figure [5D](#F5){ref-type="fig"}). This is the first evidence of a role for the CT region of Sub1, which is not conserved in human PC4, and that also provides insight into the mechanism used by Sub1 to function beyond the PIC, later on transcription. Furthermore, this is also the first demonstration that Sub1 directly interacts with RNAPII at least through the Rpb4/7 stalk.

Additionally, our data showing a genetic interaction between *SUB1, RPB4* and the *RPB1* foot domain (Figure [2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}), suggest that the function of Sub1 is negative when the integrity of RNAPII is compromised, such as in the case of *rpb4Δ* and *rpo21-4* mutants ([@B51]). One likely hypothesis is that Sub1 has a negative role during transcription initiation, repressing transcription when PIC complexes are not well assembled and/or the integrity of the polymerase is altered. Therefore, in the *rpb4Δ sub1Δ* and *rpo21-4 sub1Δ* double mutants this repression would be abolished, enabling RNAPII to circumvent initiation defects due to *rpb4Δ* ([@B81]) and *rpo21-4* ([@B51]), allowing better cell growth (Figure [2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}). On the other hand, and in agreement with this idea, overexpression of *SUB1* significantly aggravates *rpb4Δ* growth (Figure [2A](#F2){ref-type="fig"}). Our genetic data are also consistent with the proposed models for Sub1 function helping to maintain a stable PIC conformation ([@B25],[@B36]), and its putative localization within the RNAPII-DNA complex at the initiation step (Figure [8](#F8){ref-type="fig"}).

In summary, our data and that of others ([@B35],[@B36],[@B50]) allow us to propose a model of Sub1 within the initiation complex (Figure [8](#F8){ref-type="fig"}). Sub1 binds DNA through its N-terminal DBD, while is stably maintained in the RNAPII-DNA complex by binding to Rpb4/7 via its CT region (Figure [8](#F8){ref-type="fig"}). Association of Sub1 with Fcp1 explains the role of Sub1 in the modulation of CTD phosphorylation during the entire transcription cycle ([@B25]). Our results here strongly suggest that Sub1 directly interacts with Rpb7, while Fcp1 interacts with Rpb4 to modulate RNAPII CTD phosphorylation ([@B12]). In addition, Sub1 interaction with Rpb4/7 and the Rpb1 clamp domain may help to explain how it may influence TSS selection ([@B37]) and transcription elongation rate together with Spt5 ([@B38]). This is supported by the genetic interactions between *SUB1* deletion and the *rpb1-L1397S* mutation localized within the clamp domain (Figure [2C](#F2){ref-type="fig"}, and ([@B52]), and by the fact that Spt5 associates with Sub1, and interacts with Rpb4/7 and the Rpb1 clamp domain ([@B64],[@B65]).

Our study provides significant information about RNAPII transcription regulation by Sub1 and Rpb4/7, and suggests a model that could be very helpful for future structural and functional studies on RNAPII transcription machinery.
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